Systemic lupus erythematosus: pathogenesis and targeted therapy.

The disease activity, as measured by the reversal of pro-inflammatory T-cell lineage specification, exhibited a positive trend at visit 6, corresponding to 12 months of sirolimus therapy [ 130 ].

also in 11,005 other papers